JMJD4 Antikörper (AA 1-30)

Produktnummer ABIN3031514

Produktdetails anti-JMJD4 Antikörper

Target: JMJD4 (Jumonji Domain Containing 4 (JMJD4))

Bindungsspezifität: AA 1-30

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser JMJD4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Aufreinigung: Purified

Immunogen: A portion of amino acids 1-30 from the human protein was used as the immunogen for this JMJD4 antibody.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Titration of the JMJD4 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the JMJD4 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Details zu JMJD4

Target: JMJD4 (Jumonji Domain Containing 4 (JMJD4))

Andere Bezeichnung: JMJD4 (JMJD4 Produkte)

Synonyme: JMJD4 antikoerper, 6430559I23 antikoerper, RGD1307186 antikoerper, jumonji domain containing 4 antikoerper, jumonji domain containing 4 L homeolog antikoerper, JMJD4 antikoerper, jmjd4.L antikoerper, Jmjd4 antikoerper

Hintergrund: Covalent modification of histones plays critical role in regulating chromatin structure and transcription. While most covalent histone modifications are reversible, only recently has it been established that methyl groups are subject to enzymatic removal from histones. A family of novel JmjC domain-containing histone demethylation (JHDM) enzymes have been identified that perform this specific function. Histone demethylation by JHDM proteins requires cofactors Fe(II) and alpha-ketoglutarate. Family members include JHDM1 (demethylating histone 3 at lysine 36), and JHDM2A as well as JMJD2CH3K9 (both of which demethylate histone 3 at lysine 9). Contributions of histone demethylase activity to tumor development, decreases in cell proliferation, and hormone-dependent transcriptional activation have been observed.

UniProt: Q9H9V9